Literature DB >> 29494278

Adaptation of adherent-invasive E. coli to gut environment: Impact on flagellum expression and bacterial colonization ability.

Gwladys Sevrin1, Sébastien Massier1, Benoit Chassaing2, Allison Agus1, Julien Delmas1,3, Jérémy Denizot1,4, Elisabeth Billard1,4, Nicolas Barnich1,4.   

Abstract

The pathogenesis of Crohn's disease (CD) is multifactorial and involves genetic susceptibility, environmental triggers and intestinal microbiota. Adherent-invasive Escherichia coli (AIEC) are flagellated bacteria more prevalent in CD patients than in healthy subjects and promote chronic intestinal inflammation. We aim at deciphering the role of flagella and flagellin modulation by intestinal conditions. AIEC flagellum expression is required for optimal adhesion to and invasion of intestinal epithelial cells. Interestingly, differential flagellin regulation was observed between commensal E. coli (HS) and AIEC (LF82) strains: flagellum expression by AIEC bacteria, in contrast to that of commensal E. coli, is enhanced under intestinal conditions (the presence of bile acids and mucins). Flagella are involved in the ability of the AIEC LF82 strain to cross a mucus layer in vitro and in vivo, conferring a selective advantage in penetrating the mucus layer and reaching the epithelial surface. In a CEABAC10 mouse model, a non-motile mutant (LF82-ΔfliC) exhibits reduced colonization that is restored by a dextran sodium sulfate treatment that alters mucus layer integrity. Moreover, a mutant that continuously secretes flagellin (LF82-ΔflgM) triggers a stronger inflammatory response than the wild-type strain, and the mutant's ability to colonize the CEABAC10 mouse model is decreased. Overexpression of flagellin in bacteria in contact with epithelial cells can be detrimental to their virulence by inducing acute inflammation that enhances AIEC clearance. AIEC pathobionts must finely modulate flagellum expression during the infection process, taking advantage of their specific virulence gene regulation to improve their adaptability and flexibility within the gut environment.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29494278      PMCID: PMC7524368          DOI: 10.1080/19490976.2017.1421886

Source DB:  PubMed          Journal:  Gut Microbes        ISSN: 1949-0976


  72 in total

Review 1.  The anti-sigma factors.

Authors:  K T Hughes; K Mathee
Journal:  Annu Rev Microbiol       Date:  1998       Impact factor: 15.500

Review 2.  Paneth cells, antimicrobial peptides and maintenance of intestinal homeostasis.

Authors:  Charles L Bevins; Nita H Salzman
Journal:  Nat Rev Microbiol       Date:  2011-03-22       Impact factor: 60.633

Review 3.  Inflammatory bowel disease.

Authors:  Arthur Kaser; Sebastian Zeissig; Richard S Blumberg
Journal:  Annu Rev Immunol       Date:  2010       Impact factor: 28.527

4.  Regulatory and functional co-operation of flagella and type 1 pili in adhesive and invasive abilities of AIEC strain LF82 isolated from a patient with Crohn's disease.

Authors:  Nicolas Barnich; Jérôme Boudeau; Laurent Claret; Arlette Darfeuille-Michaud
Journal:  Mol Microbiol       Date:  2003-05       Impact factor: 3.501

5.  The Pic protease of enteroaggregative Escherichia coli promotes intestinal colonization and growth in the presence of mucin.

Authors:  Susan M Harrington; Jalaluddin Sheikh; Ian R Henderson; Fernando Ruiz-Perez; Paul S Cohen; James P Nataro
Journal:  Infect Immun       Date:  2009-04-06       Impact factor: 3.441

6.  OmpC and the sigma(E) regulatory pathway are involved in adhesion and invasion of the Crohn's disease-associated Escherichia coli strain LF82.

Authors:  Nathalie Rolhion; Frédéric Antonio Carvalho; Arlette Darfeuille-Michaud
Journal:  Mol Microbiol       Date:  2007-03       Impact factor: 3.501

7.  Culture independent analysis of ileal mucosa reveals a selective increase in invasive Escherichia coli of novel phylogeny relative to depletion of Clostridiales in Crohn's disease involving the ileum.

Authors:  Martin Baumgart; Belgin Dogan; Mark Rishniw; Gil Weitzman; Brian Bosworth; Rhonda Yantiss; Renato H Orsi; Martin Wiedmann; Patrick McDonough; Sung Guk Kim; Douglas Berg; Ynte Schukken; Ellen Scherl; Kenneth W Simpson
Journal:  ISME J       Date:  2007-07-12       Impact factor: 10.302

8.  Phylogenetic analysis of inflammatory bowel disease associated Escherichia coli and the fimH virulence determinant.

Authors:  Shadi Sepehri; Roman Kotlowski; Charles N Bernstein; Denis O Krause
Journal:  Inflamm Bowel Dis       Date:  2009-11       Impact factor: 5.325

9.  Human β-defensin 3 peptide is increased and redistributed in Crohn's ileitis.

Authors:  Jeffrey P Meisch; Michiko Nishimura; Ryan M Vogel; Hannah C Sung; Beth A Bednarchik; Santosh K Ghosh; Pingfu Fu; Thomas McCormick; Aaron Weinberg; Alan D Levine
Journal:  Inflamm Bowel Dis       Date:  2013-04       Impact factor: 5.325

10.  Point mutations in FimH adhesin of Crohn's disease-associated adherent-invasive Escherichia coli enhance intestinal inflammatory response.

Authors:  Nicolas Dreux; Jérémy Denizot; Margarita Martinez-Medina; Alexander Mellmann; Maria Billig; Dagmara Kisiela; Sujay Chattopadhyay; Evgeni Sokurenko; Christel Neut; Corinne Gower-Rousseau; Jean-Frédéric Colombel; Richard Bonnet; Arlette Darfeuille-Michaud; Nicolas Barnich
Journal:  PLoS Pathog       Date:  2013-01-24       Impact factor: 6.823

View more
  11 in total

1.  Host control and the evolution of cooperation in host microbiomes.

Authors:  Connor Sharp; Kevin R Foster
Journal:  Nat Commun       Date:  2022-06-22       Impact factor: 17.694

2.  YqeH contributes to avian pathogenic Escherichia coli pathogenicity by regulating motility, biofilm formation, and virulence.

Authors:  Lei Yin; Baoyan Cheng; Jian Tu; Ying Shao; Xiangjun Song; Xiaocheng Pan; Kezong Qi
Journal:  Vet Res       Date:  2022-04-18       Impact factor: 3.829

3.  Metabolic adaptation of adherent-invasive Escherichia coli to exposure to bile salts.

Authors:  Julien Delmas; Lucie Gibold; Tiphanie Faïs; Sylvine Batista; Martin Leremboure; Clara Sinel; Emilie Vazeille; Vincent Cattoir; Anthony Buisson; Nicolas Barnich; Guillaume Dalmasso; Richard Bonnet
Journal:  Sci Rep       Date:  2019-02-18       Impact factor: 4.379

Review 4.  Host/microbiota interactions in health and diseases-Time for mucosal microbiology!

Authors:  Noëmie Daniel; Emelyne Lécuyer; Benoit Chassaing
Journal:  Mucosal Immunol       Date:  2021-03-26       Impact factor: 7.313

5.  The Short-Chain Fatty Acids Propionate and Butyrate Augment Adherent-Invasive Escherichia coli Virulence but Repress Inflammation in a Human Intestinal Enteroid Model of Infection.

Authors:  Fernanda Pace; Sara E Rudolph; Ying Chen; Bin Bao; David L Kaplan; Paula I Watnick
Journal:  Microbiol Spectr       Date:  2021-10-06

6.  Mimicking the Intestinal Host-Pathogen Interactions in a 3D In Vitro Model: The Role of the Mucus Layer.

Authors:  María García-Díaz; Maria Del Mar Cendra; Raquel Alonso-Roman; María Urdániz; Eduard Torrents; Elena Martínez
Journal:  Pharmaceutics       Date:  2022-07-26       Impact factor: 6.525

Review 7.  Characteristics of Probiotic Preparations and Their Applications.

Authors:  Guangqiang Wang; Yunhui Chen; Yongjun Xia; Xin Song; Lianzhong Ai
Journal:  Foods       Date:  2022-08-16

Review 8.  Adherent-Invasive E. coli: Update on the Lifestyle of a Troublemaker in Crohn's Disease.

Authors:  Mélissa Chervy; Nicolas Barnich; Jérémy Denizot
Journal:  Int J Mol Sci       Date:  2020-05-25       Impact factor: 5.923

9.  Yersiniabactin Siderophore of Crohn's Disease-Associated Adherent-Invasive Escherichia coli Is Involved in Autophagy Activation in Host Cells.

Authors:  Guillaume Dalmasso; Hang Thi Thu Nguyen; Tiphanie Faïs; Sébastien Massier; Caroline Chevarin; Emilie Vazeille; Nicolas Barnich; Julien Delmas; Richard Bonnet
Journal:  Int J Mol Sci       Date:  2021-03-29       Impact factor: 5.923

Review 10.  Microbial adaptation to the healthy and inflamed gut environments.

Authors:  Yijie Guo; Sho Kitamoto; Nobuhiko Kamada
Journal:  Gut Microbes       Date:  2020-11-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.